A Novel Gel that can Stop Tumours

In a recent breakthrough, a novel gel has demonstrated remarkable potential in the treatment of glioblastoma, a deadly brain tumour. Researchers at Johns Hopkins University developed a hydrogel that combines an anti-cancer drug and an antibody, self-assembling into a gel that fills post-surgery grooves. This innovative gel can reach areas beyond surgical access, effectively targeting lingering cancer cells and suppressing tumour growth. In mouse trials, it achieved a 100% cure rate for glioblastoma. Additionally, the gel seems to stimulate an immune response, leading to long-term cancer resistance. This approach combines chemo and immunotherapy during surgery, offering hope for better outcomes.